Vaccine development gains speed with the new European Plotkin Institute for Vaccinology – Actualités – CIVIS – Europe’s Civic University Alliance [Aller au contenu](#main) ![](https://civis.eu/build/assets/circle-10-DJMNX6l7.svg) ![](https://civis.eu/build/assets/circle-06-H_YyMKlQ.svg) ![](https://civis.eu/build/assets/circle-03-DvaxLIQk.svg) [ ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg)](https://civis.eu/fr) - [ Découvrir ](https://civis.eu/fr/discover-civis-alliance) - [ CIVIS, c'est quoi ? ](https://civis.eu/fr/discover-civis-alliance/what-is-civis) - [ Notre travail ](https://civis.eu/fr/discover-civis-alliance/our-work) - [ Mission, Vision & Valeurs ](https://civis.eu/fr/discover-civis-alliance/our-institutional-journey) - [ Gouvernance et Gestion ](https://civis.eu/fr/discover-civis-alliance/governance-andamp-management) - [ Qui est qui? ](https://civis.eu/fr/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/fr/discover-civis-alliance/civis-association) [Open Labs & Engagement civique ](https://civis.eu/fr/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Apprendre ](https://civis.eu/fr/learn) - [ Blended Intensive Programmes ](https://civis.eu/fr/learn/blended-intensive-programmes) - [ Apprentissage flexible ](https://civis.eu/fr/learn/build-your-learning-path-with-our-modular-offer) - [ Programmes de Master ](https://civis.eu/fr/learn/find-your-master-s-programme) - [ Staff Weeks & Job Shadowing ](https://civis.eu/fr/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Étudier à l'étranger ](https://civis.eu/fr/learn/study-abroad-and-connect-with-civis-universities) [Discover the projects led by our students in 2025-2026 ](https://civis.eu/fr/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026) [CIVIS Museum University Forum ](https://civis.eu/fr/discover-civis-alliance/our-work/CIVIS-Museum-University-Forum) - [ Enseigner ](https://civis.eu/fr/teach) - [ Appels à projets ](https://civis.eu/fr/teach/civis-calls) - [ Innovez dans votre enseignement ](https://civis.eu/fr/teach/innovate-your-teaching) - [ Ressources pour les enseignants ](https://civis.eu/fr/teach/resources-for-educators) [CIVIS BIPs: impact fort et satisfaction élevée, selon un nouveau rapport ](https://civis.eu/fr/the-civis-newsroom/civis-bips-strong-impact-and-high-satisfaction-new-report-finds) [Musicians from all over CIVIS come together in Madrid to promote inclusiveness ](https://civis.eu/fr/the-civis-newsroom/musicians-from-all-over-civis-come-together-in-madrid-to-promote-inclusiveness) - [ Recherche ](https://civis.eu/fr/Recherche) - [ Collaboration en recherche ](https://civis.eu/fr/Recherche/Collaboration-en-recherche) - [ Carrières, réseaux et mobilités ](https://civis.eu/fr/Recherche/Carrières-réseaux-et-projets-de-recherche) - [ Ressources pour les chercheur·euse·s ](https://civis.eu/fr/Recherche/Ressources-pour-les-chercheur-euse-s) [CIVIS launches new job space for early-stage researchers across Europe and Africa ](https://civis.eu/fr/the-civis-newsroom/civis-launches-new-post-doc-doc-job-space-to-connect-early-stage-researchers-across-europe-and-africa) [Face à des défis communs, des solutions conjointes pour l'Afrique et l'Europe ](https://civis.eu/fr/the-civis-newsroom/facing-common-challenges-shaping-joint-solutions-for-africa-and-europe) - [ Connecter ](https://civis.eu/fr/connecter) - [ Newsletters ](https://civis.eu/fr/connecter/newsletters) - [ CIVIS Days ](https://civis.eu/fr/connecter/civis-days) - [ Société civile ](https://civis.eu/fr/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Nous contacter ](https://civis.eu/fr/contactez-nous) - [ Presse & Branding ](https://civis.eu/fr/connecter/coin-presse-identite-marque) [Faites des vagues : CIVIS lance une nouvelle série de podcasts ](https://civis.eu/fr/the-civis-newsroom/make-some-waves-civis-launches-new-podcast-series) [Fake It Till You News It: Challenges and Solutions in Modern Media Student Innovation Forum ](https://civis.eu/fr/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026/civis-creathon-contest) [ Histoires ](https://civis.eu/fr/the-civis-newsroom) fr - [ en ](https://civis.eu/en/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ de ](https://civis.eu/de/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ el ](https://civis.eu/el/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ it ](https://civis.eu/it/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ es ](https://civis.eu/es/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ sv ](https://civis.eu/sv/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ ro ](https://civis.eu/ro/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) Menu - [Découvrir](https://civis.eu/fr/discover-civis-alliance) [ Toggle submenu ](#primary-nav-sm-collapse-29) - [ CIVIS, c'est quoi ? ](https://civis.eu/fr/discover-civis-alliance/what-is-civis) - [ Notre travail ](https://civis.eu/fr/discover-civis-alliance/our-work) - [ Mission, Vision & Valeurs ](https://civis.eu/fr/discover-civis-alliance/our-institutional-journey) - [ Gouvernance et Gestion ](https://civis.eu/fr/discover-civis-alliance/governance-andamp-management) - [ Qui est qui? ](https://civis.eu/fr/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/fr/discover-civis-alliance/civis-association) - [Apprendre](https://civis.eu/fr/learn) [ Toggle submenu ](#primary-nav-sm-collapse-30) - [ Blended Intensive Programmes ](https://civis.eu/fr/learn/blended-intensive-programmes) - [ Apprentissage flexible ](https://civis.eu/fr/learn/build-your-learning-path-with-our-modular-offer) - [ Programmes de Master ](https://civis.eu/fr/learn/find-your-master-s-programme) - [ Staff Weeks & Job Shadowing ](https://civis.eu/fr/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Étudier à l'étranger ](https://civis.eu/fr/learn/study-abroad-and-connect-with-civis-universities) - [Enseigner](https://civis.eu/fr/teach) [ Toggle submenu ](#primary-nav-sm-collapse-31) - [ Appels à projets ](https://civis.eu/fr/teach/civis-calls) - [ Innovez dans votre enseignement ](https://civis.eu/fr/teach/innovate-your-teaching) - [ Ressources pour les enseignants ](https://civis.eu/fr/teach/resources-for-educators) - [Recherche](https://civis.eu/fr/Recherche) [ Toggle submenu ](#primary-nav-sm-collapse-32) - [ Collaboration en recherche ](https://civis.eu/fr/Recherche/Collaboration-en-recherche) - [ Carrières, réseaux et mobilités ](https://civis.eu/fr/Recherche/Carrières-réseaux-et-projets-de-recherche) - [ Ressources pour les chercheur·euse·s ](https://civis.eu/fr/Recherche/Ressources-pour-les-chercheur-euse-s) - [Connecter](https://civis.eu/fr/connecter) [ Toggle submenu ](#primary-nav-sm-collapse-33) - [ Newsletters ](https://civis.eu/fr/connecter/newsletters) - [ CIVIS Days ](https://civis.eu/fr/connecter/civis-days) - [ Société civile ](https://civis.eu/fr/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Nous contacter ](https://civis.eu/fr/contactez-nous) - [ Presse & Branding ](https://civis.eu/fr/connecter/coin-presse-identite-marque) [ Histoires ](https://civis.eu/fr/the-civis-newsroom) fr - [ en ](https://civis.eu/en/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ de ](https://civis.eu/de/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ el ](https://civis.eu/el/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ it ](https://civis.eu/it/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ es ](https://civis.eu/es/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ sv ](https://civis.eu/sv/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) - [ ro ](https://civis.eu/ro/the-civis-newsroom/vaccine-development-accelerated-thanks-to-the-new-european-plotkin-institute-for-vaccinology) 1. [The CIVIS Newsroom ](https://civis.eu/fr/the-civis-newsroom) 2. Vaccine development gains speed with the new European Plotkin Institute for Vaccinology Vaccine development gains speed with the new European Plotkin Institute for Vaccinology ========================================================================================= CIVIS Highlights 8 décembre 2023 Université libre de Bruxelles (ULB) inaugurated in September the European Plotkin Institute for Vaccinology, a 3,600 m2 state-of-the-art laboratory where researchers from different disciplines work together towards the same goal: to better understand, treat and prevent infectious diseases. ![](/storage/files/inauguration-de-leuropean-plotkin-institute-for-vaccinology-epiv-accelerer-le-developpement-des-vaccins-actualites-de-lulb.png) Photos: ULB The European Plotkin Institute for Vaccinology (EPIV) is a joint initiative of ULB and the University of Antwerp, supported by the Belgian federal government. At ULB, the European Plotkin Institute for Vaccinology brings together research teams in immunology and microbiology to combat infectious diseases in Belgium and around the world, and to participate in international efforts to prepare for future pandemics. It incorporates clinical research capabilities to translate the results of fundamental research into benefits for patients. Both human and material resources ---------------------------------- The Institute brings together a group of 5 research teams - and over 50 researchers already - working in the fields of immunology, bacteriology, vaccinology, virology and clinical microbiology, permanently connected to international networks to meet the challenges of current and future infectious diseases: > *In an era that demands innovation and research in healthcare, the opening of the Institute of Vaccinology next to the Brussels University Hospital represents an important combination of skills. It reinforces both our triple academic mission - combining complex care, teaching and research - and our resolute commitment to excellence and innovation. Together, we are shaping a vital ecosystem conducive to distinction, generating a strong synergy for a healthier and more resilient future in the service of our patients,* says Jean-Michel Hougardy, General Medical Director of Brussels University Hospital. The researchers have at hand a large biobank capacity for pathogens (*viruses, bacteria, parasites*) and human samples (*blood, serum, saliva, etc.*). They are studied in state-of-the-art laboratories, specially conceived for a safe handling. Also, a high-throughout testing capacity is always available and active, to help in the event of a new pandemic. Once hopes, now objectives --------------------------- The objectives of the EPIV are: - understand the precise interactions between humans and pathogens (viruses, bacteria, parasites); - identify new approaches to protecting patients from infections (vaccines, bacteriophages, new drugs); - studying in depth the immunity induced by vaccination; - identifying the specific needs of vulnerable populations to protect them more effectively against infections; - implement tools to tackle future pandemics. Considered to be the "godfather of vaccines", Stanley Plotkin - who's name was chosen for the Institute - contributed to the disappearance of rubella in the United States. He also played a major role in the development of numerous vaccines, notably against rabies, rotavirus, polio, chickenpox and cytomegalovirus. **Find out more details about EPIV by reading the [original, French story](https://actus.ulb.be/fr/presse/communiques-de-presse/recherche/inauguration-de-leuropean-plotkin-institute-for-vaccinology-epiv-accelerer-le-developpement-des-vaccins).** Related news ------------ - [ ![](https://civis.eu/storage/files/post-it-risks-800x600.jpg?token=3f32ba7f3ab0220e88eeac41defdd8bf)Micro-certification – IA et travail: accompagner ses équipes faces au changement Learn 10 février 2026 ](https://civis.eu/fr/the-civis-newsroom/civis-micro-credentials-ai-and-work-supporting-teams-through-change) - [ ![](https://civis.eu/storage/files/lisa-ardoin-carre-800x600.jpg?token=f714a0ebb1268db56d15373f824f5d1d)Living and working in the White Desert - vlogs from Antarctica by a ULB student CIVIS Highlights 16 septembre 2025 ](https://civis.eu/fr/the-civis-newsroom/antarctica-vlogs-living-and-working-in-the-white-desert) - [ ![](https://civis.eu/storage/files/eurosud-iee-consilium-copy-800x600.jpeg?token=d7e48b887b15ee3e7750a627f84b5b8e)EUROSUD: A passport to civic-minded expertise on Southern Europe Study programmes 8 juillet 2025 ](https://civis.eu/fr/the-civis-newsroom/eurosud-a-passport-to-civic-minded-expertise-on-southern-europe) [Découvrez toutes nos aventures](https://civis.eu/fr/the-civis-newsroom) [ New fundings for the eBelong project. Sense of Belonging is now approached in the context of new HE alliances ](< https://civis.eu/fr/the-civis-newsroom/ebelong-sense-of-belonging-continues >) [ Music and history welcomed first-year students at NKUA ](< https://civis.eu/fr/the-civis-newsroom/first-year-students-at-nkua-welcomed-with-a-one-off-musical-celebration-for-the-first-time-in-history >) ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg) ------------------------------------------------------------------------------------------------- Europe’s Civic University Alliance ![Co-funded by the European Union](https://civis.eu/build/assets/co-funded-by-the-european-union-DSKLW1us.png)Views and opinions expressed do not necessarily reflect those of the European Union or the European Education and Culture Executive Agency (EACEA). Neither can be held responsible for them. ### Personnes - [ Étudiant·e ](https://civis.eu/fr/i-am-a-student) - [ Académique et chercheur·euse ](https://civis.eu/fr/je-suis-academique-chercheur-euse) - [ Administrateur·rice ](https://civis.eu/fr/i-am-an-administrator) - [ Société civile ](https://civis.eu/fr/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Coin presse ](https://civis.eu/fr/connecter/coin-presse-identite-marque) ### Liens utiles - [ Ressources ](https://civis.eu/fr/resources) - [ CIVIS Agora ](https://civis.eu/fr/civis-agora-the-operational-hub-of-the-civis-digital-campus) - [ Initiative des universités européennes ](https://civis.eu/fr/european-universities-initiative) - [ Événements passés ](https://civis.eu/fr/past-events) - [ Contact ](https://civis.eu/fr/contactez-nous) [Newsletters](https://civis.eu/fr/connecter/newsletters) ### Social networks - [ ![](https://civis.eu/storage/files/instagram.svg) Instagram ](https://www.instagram.com/civis.eu/) - [ ![](https://civis.eu/storage/files/linkedin.svg) LinkedIn ](https://www.linkedin.com/company/civis-eu) - [ ![](https://civis.eu/storage/files/facebook.svg) Facebook ](https://www.facebook.com/CIVISEuropeanUniversity/) - [ ![](https://civis.eu/storage/files/youtube.svg) YouTube ](https://www.youtube.com/channel/UCdCm0FfreX81BuNH-znlRGQ) © 2026 – CIVIS – All rights reserved - [ Cookie Policy ](https://civis.eu/fr/politique-de-cookies) - [ Privacy policy ](https://civis.eu/fr/privacy-policy) Website by [Typi Design](https://typi.be) • Design by [Atelier Milky](https://ateliermilky.com) [ ](#top) Search